Theralase Technologies Inc. (TLT) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.05x

Theralase Technologies Inc. (TLT) has a Cash Flow Reinvestment Rate of 0.05x as of September 2018, reinvesting CA$19.98K (capex CA$19.98K ) from operating cash flow of CA$436.21K. Explore TLT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.05x

(Capex + Investments) / Operating CF

Total Reinvested

CA$19.98K

Capex + Investments

Operating Cash Flow

CA$436.21K

CAD

Capital Expenditures

CA$19.98K

CAD

Theralase Technologies Inc. Cash Flow Reinvestment Rate (2005–2005)

Historical reinvestment intensity for Theralase Technologies Inc. across 1 annual periods. Also explore balance sheet size of Theralase Technologies Inc. for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Theralase Technologies Inc. (2005–2005)

Year-by-year capital reinvestment analysis for Theralase Technologies Inc.. For live market cap and broader valuation context, see market cap of Theralase Technologies Inc..

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2005	1.00x	CA$85.30K	CA$85.33K	CA$85.30K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow